z-logo
Premium
ESCD invited speaker abstracts: Focus Sessions
Author(s) -
Marielouise Schuttelaar,
PieterJan Coenraads,
Brunhilde Blömeke,
Carsten Goebel
Publication year - 2016
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/cod.12634
Subject(s) - focus (optics) , medicine , medical education , psychology , audiology , optics , physics
The introduction of a methoxymethyl side chain into para-phenylenediamine (PPD) resulted in the development of a new hair dye molecule: 2-methoxymethyl-para-phenylenediamine (Me-PPD). Besides having excellent hair colouring properties, this PPD derivate has significantly lower skin-sensitizing properties than PPD and toluene-2,5-diamine. In a simulated hair dye model (i.e. open-use test), cross-reactivity to Me-PPD occurred in PPD-allergic individuals, but the number of cross-reactors was substantially lower than one would expect in an open-use test with a PPD-containing hair dye. Patch testing with Me-PPD has never been performed. The current study aimed to find the optimal patch-test concentration for detecting cross-reactivity to Me-PPD. PPD-allergic patients with a documented history of hair dye-related allergy, and different grades (+, ++, ) of positive patch-test reactions to PPD, will be included in the study. Patch testing will be performed with Me-PPD 0.1%, 0.25%, 0.5%, 1.0% and 2.0% in petrolatum. In a simulated hair dye use model on the volar forearm, the reactivity to use concentrations of Me-PPD 2% and PPD 2% will be investigated. On the adjacent skin a similar open-use test with the same basic formula, but without Me-PPD or PPD, will be applied as a control. After 45min the hair dye will be removed from the skin surface by rinsing with water. Reading of the patch tests and the open-use tests will be performed at days 2, 3 and 7, according to the International Contact Dermatitis Research Group reading criteria. In total 30 PPD-allergic individuals will be included in this Me-PPD dose-finding pilot study. At the moment a number of individuals have been enrolled; full data will be available at the meeting

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom